Literature DB >> 23343965

Predictive factors associated with the success of pneumatic dilatation in Japanese patients with primary achalasia: a study using high-resolution manometry.

Hiroshi Yamashita1, Kiyoshi Ashida, Takumi Fukuchi, Yoshiaki Nagatani, Hideaki Koga, Kasane Senda, Takaaki Eguchi, Satoshi Ubukata, Shinpei Kawaguchi, Aya Ueda, Toshio Tanaka, Rina Ohashi, Dai Ito.   

Abstract

BACKGROUND/AIMS: A new classification of achalasia using high-resolution manometry (HRM) has recently been suggested. Pneumatic dilatation (PD) is a common treatment for primary achalasia. The usefulness of the new classification and HRM for the treatment and follow-up of patients after PD is unknown. The aim of this study was to evaluate the PD effectiveness and the predictive factors of success in Japanese patients with achalasia using HRM and the new classification of achalasia.
METHODS: Twenty-five patients were diagnosed with primary achalasia using HRM and treated by PD in our hospital. We evaluated symptom scores and esophageal manometry 6 and 12 months after the first PD.
RESULTS: After the first PD treatment, remission occurred in 24 out of 25 (96.0%) patients at 6 months and in 19 out of 25 (76.0%) patients at 12 months. With the new classification of achalasia, the success rates were 83.3, 80.0 and 50% for types I, II and III, respectively, 12 months after PD. The median age of the successful group was significantly greater than that of the failure group (47.1 vs. 37.0 years, p < 0.05). The median residual lower esophageal sphincter (LES) pressure 6 months after PD in the successful group was significantly lower than that of the failure group (9.0 vs. 15.5 mm Hg, p < 0.05).
CONCLUSION: Good predictors of PD success were old age (>40 years) and residual LES pressures less than 15 mm Hg 6 months after PD.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23343965     DOI: 10.1159/000343902

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  13 in total

1.  Peroral Endoscopic Myotomy for Type III Achalasia of Chicago Classification: Outcomes with a Minimum Follow-Up of 24 Months.

Authors:  Wengang Zhang; En-Qiang Linghu
Journal:  J Gastrointest Surg       Date:  2017-03-17       Impact factor: 3.452

2.  Value of Multidetector Computed Tomography in the Assessment of Achalasia Subtypes and Detection of Pulmonary and Thoracic Complications.

Authors:  Sanja Jovanovic; Aleksandra Djuric-Stefanovic; Aleksandar Simić; Ognjan Skrobic; Predrag Pesko
Journal:  Med Princ Pract       Date:  2019-05-22       Impact factor: 1.927

3.  Correlation Between Timed Barium Esophagogram and Esophageal Transit Scintigraphy Results in Achalasia.

Authors:  Yoo Mi Park; Han Ho Jeon; Jae Jun Park; Jie-Hyun Kim; Young Hoon Youn; Hyojin Park
Journal:  Dig Dis Sci       Date:  2015-04-30       Impact factor: 3.199

Review 4.  High-resolution manometry in diagnosis and treatment of achalasia: help or hype.

Authors:  Joel E Richter
Journal:  Curr Gastroenterol Rep       Date:  2014-12

5.  For patients with primary achalasia the clinical success of pneumatic balloon dilatation can be predicted from the residual fraction of radionuclide during esophageal transit scintigraphy.

Authors:  Han Ho Jeon; Young Hoon Youn; Kwangwon Rhee; Jie-Hyun Kim; Hyojin Park; Jeffrey L Conklin
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

6.  Comparison of the Outcomes of Peroral Endoscopic Myotomy for Achalasia According to Manometric Subtype.

Authors:  Won Hee Kim; Joo Young Cho; Weon Jin Ko; Sung Pyo Hong; Ki Baik Hahm; Jun-Hyung Cho; Tae Hee Lee; Su Jin Hong
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

7.  Peroral endoscopic myotomy (POEM) vs pneumatic dilation (PD) in treatment of achalasia: A meta-analysis of studies with ≥ 12-month follow-up.

Authors:  Andrew Ofosu; Babu P Mohan; Yervant Ichkhanian; Maen Masadeh; John Febin; Mohamed Barakat; Daryl Ramai; Saurabh Chandan; Gulara Haiyeva; Shahab R Khan; Mohamad Aghaie Meybodi; Antonio Facciorusso; Alessandro Repici; Sachin Wani; Nirav Thosani; Mouen A Khashab
Journal:  Endosc Int Open       Date:  2021-06-21

8.  Safety and efficacy of botulinum toxin injection therapy for esophageal achalasia in Japan.

Authors:  Daisuke Yamaguchi; Nanae Tsuruoka; Yasuhisa Sakata; Ryo Shimoda; Kazuma Fujimoto; Ryuichi Iwakiri
Journal:  J Clin Biochem Nutr       Date:  2015-10-17       Impact factor: 3.114

9.  Clinical characteristics and treatment outcomes of 3 subtypes of achalasia according to the chicago classification in a tertiary institute in Korea.

Authors:  Ju Yup Lee; Nayoung Kim; Sung Eun Kim; Yoon Jin Choi; Kyu Keun Kang; Dong Hyun Oh; Hee Jin Kim; Kwung Jun Park; A Young Seo; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Jin-Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Dong Ho Lee
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

10.  The early efficacy of Heller myotomy in the treatment of Iranian patients with achalasia.

Authors:  Saeed Abdi; Mojgan Forotan; Abdolrahim Nikzamir; Saeedeh Zomorody; Somayeh Jahani-Sherafat
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.